Phase 1 Study of OSI-930 in Cancer Patients

Clinical trial NCT00513851 · COMPLETED

Trial details

NCT number: NCT00513851
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2006-04-01
Primary completion: 2009-07-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.